ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ORGO Organogenesis Holdings Inc

2.50
0.01 (0.40%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 895,051
Bid Price 2.47
Ask Price 2.80
News -
Day High 2.64

Low
1.91

52 Week Range

High
4.705

Day Low 2.455
Share Name Share Symbol Market Stock Type
Organogenesis Holdings Inc ORGO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.40% 2.50 23:00:10
Open Price Low Price High Price Close Price Previous Close
2.48 2.455 2.64 2.50 2.49
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
6,541 895,051 US$ 2.55 US$ 2,281,388 - 1.91 - 4.705
Last Trade Type Quantity Price Currency
17:23:47 24 US$ 2.46 USD

Organogenesis Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
329.91M 131.96M - 433.14M 4.95M 0.04 66.67
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Organogenesis News

Date Time Source News Article
5/02/202406:00GlobeNewswire Inc.Organogenesis Achieves Primary Endpoint in Phase 3 Clinical..
4/16/202406:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of..
4/03/202406:30GlobeNewswire Inc.Organogenesis Announces Favorable Court Ruling Dismissing..
2/29/202415:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202415:05Edgar (US Regulatory)Form 8-K - Current report
2/29/202415:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and..
2/23/202416:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202416:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202416:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202416:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202416:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202416:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ORGO Message Board. Create One! See More Posts on ORGO Message Board See More Message Board Posts

Historical ORGO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.292.922.262.461,134,5240.219.17%
1 Month2.783.0652.1652.751,381,446-0.28-10.07%
3 Months3.643.862.1652.89918,841-1.14-31.32%
6 Months2.394.7051.963.00949,5080.114.60%
1 Year1.934.7051.913.09945,3510.5729.53%
3 Years23.6923.991.7956.631,018,322-21.19-89.45%
5 Years7.8524.33631.7957.14719,010-5.35-68.15%

Organogenesis Description

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Your Recent History

Delayed Upgrade Clock